UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME
Sales, net	$ 10,005	$ 12,505	$ 31,745	$ 37,891
Cost of goods sold	4,203	5,146	12,925	14,951
Gross profit	5,802	7,359	18,820	22,940
Operating expense
Selling, general and administrative	2,287	3,252	7,464	9,693
Research & development	172	138	692	414
Total operating expense	2,459	3,390	8,156	10,107
Operating income	3,343	3,969	10,664	12,833
Other income	836	812	2,524	2,239
Income before provision for income taxes	4,179	4,781	13,188	15,072
Provision for income taxes	616	846	2,216	2,723
Net income	$ 3,563	$ 3,935	$ 10,972	$ 12,349
Earnings per common share (basic)	$ 1.02	$ 1.08	$ 3.1	$ 3.4
Earnings per common share (diluted)	$ 1.02	$ 1.08	$ 3.1	$ 3.39
Shares outstanding - basic	3,478	3,629	3,542	3,629
Shares outstanding - diluted	3,478	3,639	3,542	3,638
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ 1,432	$ (1,012)	$ 769	$ 41
Total comprehensive income	$ 4,995	$ 2,923	$ 11,741	$ 12,390